£166.98

CRC Press Gene Regulation and Therapeutics for Cancer

Price data last checked 97 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the most expensive it has ever been. Walk away.

£167 today · previous high £167 · all-time low £128

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 564 days • 564 data points (No recent data available)

Historical
Generating forecast...
£166.98 £124.63 £133.87 £143.11 £152.35 £161.59 £170.83 01 August 2024 19 December 2024 09 May 2025 27 September 2025 15 February 2026

Price Distribution

Price distribution over 564 days • 8 price levels

Days at Price
Current Price
236 days 36 days 24 days 44 days 75 days 74 days 43 days 32 days · current 0 59 118 177 236 £129 £134 £136 £137 £145 £148 £149 £167 Days at Price

Price Analysis

Most common price: £129 (236 days, 41.8%)

Price range: £129 - £167

Price levels: 8 different prices over 564 days

Description

Differential gene regulation and targeted therapy are the critical aspects of several cancers. This book covers specific gene regulation and targeted therapies in different malignancies. It offers a comprehensive assessment of the transcriptional dysregulation in cancer, and considers some examples of transcriptional regulators as definitive oncogenic drivers in solid tumors, followed by a brief discussion of transcriptional effectors of the programs they drive, and discusses its specific targets. Most targeted therapeutics developed to date have been directed against a limited set of oncogenic drivers, exemplified by those encoding cell surface or cytoplasmic kinases that function in intracellular signaling cascades. About the Author Surinder K. Batra is a Professor and Chairman of the Department of Biochemistry and Molecular Biology at the University of Nebraska Medical Center. Dr. Batra studies the functions of mucins in the progression of different malignancies. His recent studies demonstrated the molecular mechanism for the progression and metastasis of multiple cancers. His investigations led to developing several targeted therapies for different tumors. Based on his mechanistic and translational studies, different targets entered into Phase I/II trials for various cancers. Moorthy P. Ponnusamy is an Associate Professor of Biochemistry and Molecular Biology at the University of Nebraska Medical Centre. Dr. Ponnusamy’s research background reflects a keen interest in understanding the molecular mechanisms of cancer stem cell-mediated progression and metastatis of pancreatic cancer. His recent studies discovered the specific mechanism for pancreatic cancer stem cell maintenance and its impact on metastatis. He is developing small molecules to target cancer stem cell populations.

Product Specifications

Format
Hardcover
Domain
Amazon UK
Release Date
22 March 2021
Listed Since
31 October 2018

Barcode

No barcode data available

Similar Products You Might Like

Advances in Cancer Signal Transduction and Therapy
96% match

Advances in Cancer Signal Transduction and Therapy

Bentham Science Publishers

£82.52 09 Apr 2026
Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)
96% match

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Springer

£84.17 13 Apr 2026
Small Molecules for Cancer Treatment
96% match

Small Molecules for Cancer Treatment

Springer

£162.73 06 Feb 2026
Breast Cancer Metastasis and Drug Resistance: Challenges and Progress: 1152 (Advances in Experimental Medicine and Biology, 1152)
96% match

Breast Cancer Metastasis and Drug Resistance: Challenges and Progress: 1152 (Advances in Experimental Medicine and Biology, 1152)

Springer

£148.75 08 Mar 2026
Personalized Cancer Chemotherapy: An Effective Way of Enhancing Outcomes in Clinics
96% match

Personalized Cancer Chemotherapy: An Effective Way of Enhancing Outcomes in Clinics

Woodhead Publishing

£111.97 19 Apr 2026
Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)
96% match

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Springer

£87.81 18 Apr 2026
Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)
96% match

Biotargets of Cancer in Current Clinical Practice (Current Clinical Pathology)

Humana

£141.36 10 Mar 2026
Cancer Biology and Therapeutics
96% match

Cancer Biology and Therapeutics

Springer

£165.87 02 Mar 2026
Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
96% match

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Academic Press

£111.19 10 Mar 2026
Cancer Biology and Therapeutics
96% match

Cancer Biology and Therapeutics

Springer

£148.77 13 Jan 2026
Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)
96% match

Cancer Drug Resistance: Overviews and Methods: 1395 (Methods in Molecular Biology, 1395)

Humana

£87.47 24 Feb 2026
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
96% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.09 28 Feb 2026
Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)
96% match

Overcoming Drug Resistance in Gynecologic Cancers (Volume 17) (Cancer Sensitizing Agents for Chemotherapy, Volume 17)

Academic Press

£117.19 06 Mar 2026
Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 1991: 74 (Developments in Oncology, 74)
95% match

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 1991: 74 (Developments in Oncology, 74)

Springer

£239.60 19 Feb 2026
Targeted Therapies in Oncology
95% match

Targeted Therapies in Oncology

CRC Press

£56.99 20 Feb 2026
Drug Resistance in Cancer Cells
95% match

Drug Resistance in Cancer Cells

Springer

£107.73 08 Apr 2026
Therapeutic Strategies in Cancer Biology and Pathology
95% match

Therapeutic Strategies in Cancer Biology and Pathology

Elsevier

£89.99 08 Mar 2026
Small Molecules in Oncology: 201 (Recent Results in Cancer Research)
95% match

Small Molecules in Oncology: 201 (Recent Results in Cancer Research)

Springer

£105.50 05 Mar 2026
Animal Models in Cancer Drug Discovery
95% match

Animal Models in Cancer Drug Discovery

Academic Press

£117.49 05 Apr 2026
Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 27–29, 1991: 74 (Developments in Oncology)
95% match

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 27–29, 1991: 74 (Developments in Oncology)

Springer

£236.26 23 Feb 2026
Cancer Chemotherapy: Basic Science to the Clinic
95% match

Cancer Chemotherapy: Basic Science to the Clinic

Wiley-Blackwell

£47.19 16 Feb 2026
Advances in Cancer Research: 77: Volume 77
95% match

Advances in Cancer Research: 77: Volume 77

Academic Press

£90.19 08 Mar 2026
Evolution-adjusted Tumor Pathophysiology:: The Novel Language of Tumor Biology
95% match

Evolution-adjusted Tumor Pathophysiology:: The Novel Language of Tumor Biology

Springer

£107.67 01 Apr 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
95% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£165.95 09 Apr 2026